Trial Profile
Efficacy of Tocilizumab in the Treatment of Refractory Uveitis in Children
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jun 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Uveitis
- Focus Adverse reactions; Therapeutic Use
- 19 Jun 2015 New trial record